title: [Sexual dysfunction in men in the first 9 months after myocardial infarction].
abstract: OBJECTIVE
  The aim of the study is to assess the frequency of sexual dysfunction in men after myocardial infarction (MI).
  
  
  METHODS
  62 men were asked to fill IIEF 15 to assess sexual dysfunction 3 and 9 months after MI. RESULTS. Erectile dysfunction (ED), orgasmic dysfunction, decreased sexual desire, decreased intercourse satisfaction, decreased overall satisfaction were recognized respectively by: 61.3%, 24.2%, 62.9%, 71%, 54.8% of men 3 months after MI, and 51.6%, 17.7%, 58.1%, 77.4%, 59.7% of men 9 months after MI. Men with ED had higher serum CRP (5.8 vs. 3.8; p = 0.04) and creatinine (1 vs. 0.9; p = 0.04) levels in the peri-infarction period and higher serum BNP (47.4 vs. 24.6; p = 0.04) measured 3 months after MI than men without ED. They had also higher serum testosterone levels than men without ED (12.6 vs. 10.6; p = 0.03). Men with decreased sexual desire had significantly lower serum DHEAs (dehydroepiandrosterone sulfate) levels in the peri-infarction period than men with normal sexual desire (191.1 vs. 224.3; p = 0.044). Men with ED 9 months after MI had higher serum CRP levels in the peri-infarction period (7.5 vs. 4.6; p = 0.0371). Men with orgasmic dysfunction had lower left ventricular ejection fraction (EF) measured in the peri-infarction period (0.4 vs. 0.5; p = 0.0318).
  
  
  CONCLUSIONS
  1. Men with ED have higher serum CRP and creatinine levels in the peri-infarction period. 2. DHEAs level has an influence on sexual desire and on erectile function after MI. 3. BNP level in post-MI patients affects erectile function. 4. EF has an impact on orgasmic function.
authors.forename: Bartosz
authors.initials: B
authors.lastname: Puchalski
authors.forename: Filip
authors.initials: F
authors.lastname: Szymański
authors.forename: Robert
authors.initials: R
authors.lastname: Kowalik
authors.forename: Krzysztof Jerzy
authors.initials: KJ
authors.lastname: Filipiak
mesh_terms: D000368:Aged; D001294:Attitude to Health; D002097:C-Reactive Protein / Q000032:analysis; D003687:Dehydroepiandrosterone / Q000097:blood; D007172:Erectile Dysfunction / Q000097:blood / Q000209:etiology* / Q000523:psychology*; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000523:psychology* / Q000534:rehabilitation; D012189:Retrospective Studies
chemical_list: D003687:Dehydroepiandrosterone; D002097:C-Reactive Protein